HER2 LOW BREAST CARCINOMA

Clinical trials for HER2 LOW BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HER2 LOW BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for HER2 LOW BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Promising new combo aims to shrink Hard-to-Treat breast tumors before surgery

Disease control Ongoing

This study tests whether adding the targeted drug pyrotinib to standard chemotherapy can better shrink tumors before surgery in people with a specific type of early breast cancer (HR-positive, HER2-low, high-risk). About 160 participants will receive either the drug combo or chem…

Matched conditions: HER2 LOW BREAST CARCINOMA

Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated May 19, 2026 11:49 UTC

HER2 LOW BREAST CARCINOMA

Get alerted when new HER2 LOW BREAST CARCINOMA trials appear

Promising new combo aims to shrink Hard-to-Treat breast tumors before surgery